Cancer Research SABCS  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 1844, March 1, 2009. Published Online First February 17, 2009;
doi: 10.1158/0008-5472.CAN-08-4133
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0008-5472.CAN-08-4133v1
69/5/1844    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Martino, I.
Right arrow Articles by Fusco, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Martino, I.
Right arrow Articles by Fusco, A.

Cell, Tumor, and Stem Cell Biology

HMGA Proteins Up-regulate CCNB2 Gene in Mouse and Human Pituitary Adenomas

Ivana De Martino1,5, Rosa Visone1,5, Anne Wierinckx6, Dario Palmieri1,5, Angelo Ferraro5, Paolo Cappabianca2, Gennaro Chiappetta4, Floriana Forzati1,5, Gaetano Lombardi3, Annamaria Colao3, Jacqueline Trouillas6, Monica Fedele1,5 and Alfredo Fusco1,5

1 Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Facoltà di Medicina e Chirurgia di Napoli, 2 Dipartimento di Scienze Neurologiche, Divisione di Neurochirurgia, and 3 Dipartimento di Endocrinologia, Universita' degli Studi di Napoli Federico II, 4 Istituto Nazionale dei Tumori, Fondazione Pascale, and 5 Naples Oncogenomic Center-CEINGE, Biotecnologie Avanzate-Napoli and SEMM-European School of Molecular Medicine-Naples Site, Naples, Italy; and 6 Institut National de la Sante et de la Recherche Medicale, Lyon, France

Requests for reprints: Monica Fedele, Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, via Pansini 5, 80131 Naples, Italy. Phone: 39-081-7463054; Fax: 39-081-7463749; E-mail: mfedele{at}unina.it or monica.fedele{at}cnr.it or Alfredo Fusco, Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, via Pansini 5, 80131 Naples, Italy. Phone: 39-081-7463602; Fax: 39-081-2296674; E-mail: afusco{at}napoli.com or alfusco{at}unina.it.

Key Words: HMGA • cyclin B2 • pituitary adenoma • transgenic mice

The high mobility group As (HMGAs) belong to a family of nonhistone nuclear proteins that orchestrate the assembly of nucleoprotein complexes. Through a complex network of protein-DNA and protein-protein interaction, they play important roles in gene transcription, recombination, and chromatin structure. This protein family is involved, through different mechanisms, in both benign and malignant neoplasias. We have recently reported that transgenic mice carrying the Hmga1 or Hmga2 genes under transcriptional control of the cytomegalovirus promoter develop pituitary adenomas secreting prolactin and growth hormone. We have shown that the mechanism of the HMGA2-induced pituitary adenoma is based on the increased E2F1 activity. The expression profile of mouse normal pituitary glands and adenomas induced in HMGA transgenic mice revealed an increased expression of the ccnb2 gene, coding for the cyclin B2 protein, in the neoplastic tissues compared with the normal pituitary gland. Here, we show, by electrophoretic mobility shift assay and chromatin immunoprecipitation, a direct binding of HMGA proteins to the promoter of ccnb2 gene, whereas luciferase assays showed that HMGAs are able to up-regulate ccnb2 promoter activity. Finally, we report an increased CCNB2 expression in human pituitary adenomas of different histotypes that is directly correlated with HMGA1 and HMGA2 expression. Because cyclin B2 is involved in the regulation of the cell cycle, these results taken together indicate that HMGA-induced cyclin B2 overexpression gives an important contribution to experimental and human pituitary tumorigenesis. [Cancer Res 2009;69(5):1844–50]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.